Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels

Acta Cardiologica

Volumn 60, Issue 6, 2005, Pages 599-604

  Adiloglu, Ali K ^a,d   Can, Rabia ^b   Kinay, Ozan ^c   Aridogan, Buket C ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Microbiology Department   (Turkey)

^c Training and Research Hospital   (Turkey)

^d NONE   (Turkey)

Author keywords

Apolipoprotein B; Chlamydia pneumoniae; Helicobacter pylori; Immunoglobulin

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANGIOCARDIOGRAPHY; ANTIBODY BLOOD LEVEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL INFECTION; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; RISK FACTOR;

AGE DISTRIBUTION; ANTIBODIES, BACTERIAL; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INCIDENCE; LINEAR MODELS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TURKEY;

EID: 28944435354     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.6.2004930     Document Type: Article

References (29)

1. Gallin JI, Kaye D, O'Leary WM. Serum lipids in infection. N Engl J Med 1969; 281: 1081-6.
2. Farshtchi D, Lewis VJ. Effects of three bacterial infections on serum lipids of rabbits. J Bacteriol 1968; 95: 1615-21.
3. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia TWAR with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-6.
4. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, Kes S, Tokgozoglu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000; 38: 4408-11.
5. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001; 32: 385-91.
6. Juvonen J, Juvonen T, Laurila HM, Alakarppa H, Lounatmaa K, Surcel HM, Leinonen M, Kairaluoma MI and Saikku P. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997; 25: 499-505.
7. Padoki F, Abdel-Salam OME, Debreceni A, Mozsik G. Helicobacter pylon: One bacterium and a broad spectrum of human disease. J Physiol 2000; 94: 139-52.
8. Adiloglu AK, Nazli C, Cicioglu-Aridogan B, Kinay O, Can R, Ergene O. Gastroduodenal Helicobacter pylori infection diagnosed by Helicobacter pylori stool antigen is related to atherosclerosis. Acta Cardiol 2003; 58: 335-9.
9. Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2910-3.
10. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study. BMJ 1997; 314: 1456-7.
11. Laurila AL, Bloigu A, Nayha S, Hassi J, Leinonen M and Saikku P. Chlamydia pneumoniae antibodies associated with altered serum lipid profile. Int J Circumpolar Health 1998; 57(suppl 1): 329-32.
12. Sniderman AD, Keech FA, van Lennep JER, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary and as targets for statin treatment. Lancet 2003; 361: 777-80.
13. Kruger D, Stierle U, Hermann G, Simon R, Sheikhzadeh A. Exercise induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (dilated coronaropathy). J Am Coll Cardiol 1999; 34: 1461-70.
14. Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon ATR, Grant PJ. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardivasc Res 1997; 35: 120-4.
15. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026-33.
16. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Despres JP. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273-8.
17. Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA, Brenner H, Hombach V, Koenig W. Current infection with Helicobacter pylori but not seropositivity to Chlamydia pneumoniae or Cytomegalovirus, is associated with an atherogenic modified lipid profile. Arterioscler Thromb Vasc Biol 2001; 21: 427-32.
18. Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999; 103: 747-53.
19. Campbell LA, O'Brien ER, Cappucio AL, Kuo CC, Wang SP, Stewart D, Patton DL, Cummings PK and Grayston JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585-8.
20. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-400.
21. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987; 80: 184-90.
22. Murray LJ, Bamford KB, O'Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74: 497-501.
23. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999; 142: 207-10.
24. Haidari M, Moghadam M, Chinicar M, Ahmadieh A, Doosti M. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients. Clin Biochem 2001; 34: 149-55.
25. Bennet A, Prince JA, Fei G, Kyrenas L, Huang Y, Wiman B, Frostegard J, Faire U. Interleukin 6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003; 17: 359-67.
26. Falsetti HL, Carroll RJ. Coronary artery aneurysm. Chest 1976; 69: 630-6.
27. Swanton RH, Lea-Thomas M, Coltarte DJ, Jenkins BS, Webb-Peploe MM, Williams BT. Coronary artery ectasia, a variant of occlusive coronary arteriosclerosis. Br Heart J 1978; 40: 393-400.
28. Genda A, Nakayama A, Shimizu M, Nunoda S, Sugihara N, Suematzu T, Kita Y, Yoshimura A, Koizumi J and Mabuchi H. Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia. Atherosclerosis 1987; 66: 29-36.
29. Sudhir K, Ports TA, Amidon TM, Goldberger JJ, Brushan V, Kane JP, Yock P, Malloy MJ. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation 1995; 91: 1375-80.